Daniel Loeb — Strata Critical Medical, Inc. — SCHEDULE 13D ownership disclosure

by Oct 16, 2026Active Ownership Disclosures

Written by Andreas Torgersen · BSc Finance, BI Norwegian Business School · 20+ years across financial services, entrepreneurship and market research · Editorial standards
Active ownership · SCHEDULE 13D

Daniel Loeb’s Third Point LLC reported 5,126,511.00 shares of Strata Critical Medical, Inc., representing 5.8 % beneficial ownership. The filing was filed on 2026-10-15.

Ownership5.8 %
Shares reported5,126,511.00
Filing date2026-10-15

Disclosure details

Tracked investor Daniel Loeb
Reporting manager Third Point LLC
Issuer Strata Critical Medical, Inc.
Share class Common Stock, par value $0.0001 per share
CUSIP 092667104
Form SCHEDULE 13D
Filing date 2026-10-15
Event date 10/13/2026
Beneficially owned shares 5,126,511.00
Beneficial ownership 5.8 %
SEC accession 0000899140-26-001108

Purpose of the transaction

Item 4 contains the reporting persons’ complete explanation of the transaction’s purpose, including any plans, proposals, agreements or changes since the preceding filing.

Campaign status

A prior Schedule 13G exists in the manager’s submission history. This is treated as a possible transition unless the issuer, share class or CUSIP and reporting persons match exactly.

Continue exploring

Data methodology: This record was automatically extracted from an official SEC filing and passed MarketInsiderLab’s structured-field checks before publication. Schedule 13D beneficial ownership is not a 13F portfolio weight and is excluded from all 13F portfolio-percentage calculations. Found a possible data issue? Contact MarketInsiderLab.
About the Stock Teaser Decoder
The Stock Teaser Decoder is MarketInsiderLab’s ongoing research series examining the stock ideas promoted through newsletters, ads, and viral campaigns.
Each decode focuses on what’s being claimed, what’s verifiable, and how much of the upside rests on narrative versus data.

Related Articles

Laget for å bli lest på 20 sekunder eller mindre

Considering a Trading Platform?
For readers looking to track markets or test ideas discussed in our research, we maintain an independent comparison of major trading platforms based on regulation, costs, and usability.

→ View trading platform comparison